凯杰生物 QGEN
$50.33 −$0.53 (-1.04%)
休市 · Nov 7, 9:50 pm ET · 最新盘后价 $50.40 +0.14%
开盘$50.42
昨收$50.86
当日区间$50.26 – $50.50
成交量3.39M
市值$10.39B
市盈率（TTM）27.7
股息率0.70%
基本面
最新报告季度：Q2, ended Jun 2026
营收$535.04M+0.3% YoY
营业利润$140.85M+3.6% YoY
净利润$103.40M+7.4% YoY
摊薄每股收益$0.50+8.0% YoY
自由现金流$157.32M+30.5% YoY
经营现金流$200.69M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率62.2%
营业利润率24.6%
净利率19.5%
净资产收益率11.9%
资产收益率7.0%
投入资本回报率7.9%
流动比率2.85
负债/资产比率43.0%
现金及投资$793.50M
总负债$1.64B
净现金（净负债）-$850.12M
自由现金流/营收21.0%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $535.04M | $492.32M | $2.09B | $540.42M | $532.58M |
| 营业总收入 | $535.04M | $492.32M | $2.09B | $540.42M | $532.58M |
| 营业成本 | $194.65M | $182.72M | $790.50M | $215.15M | $201.32M |
| 毛利润 | $340.39M | $309.60M | $1.30B | $325.27M | $331.26M |
| 营业费用 | $199.54M | $192.98M | $779.19M | $203.39M | $193.97M |
| 销售及管理费用 | $146.77M | $142.39M | $583.67M | $153.88M | $143.11M |
| -销售及营销费用 | $116.68M | $114.61M | $457.99M | $120.74M | $112.82M |
| -管理费用 | $30.09M | $27.78M | $125.68M | $33.13M | $30.29M |
| 研发费用 | $50.43M | $48.26M | $187.52M | $47.24M | $48.75M |
| 折旧、摊销与折耗 | $2.34M | $2.33M | $8.00M | $2.28M | $2.11M |
| -折旧与摊销 | $2.34M | $2.33M | $8.00M | $2.28M | $2.11M |
| 营业利润 | $140.85M | $116.63M | $520.31M | $121.88M | $137.29M |
| 非经营性利息净收入（支出） | -$661,000.00 | -$489,000.00 | $31.06M | $9.86M | $6.85M |
| 非经营性利息收入 | $9.36M | $10.56M | $64.32M | $20.00M | $15.07M |
| 非经营性利息支出 | $10.02M | $11.05M | $33.26M | $10.14M | $8.22M |
| 其他收入（支出） | -$8.08M | -$30.31M | -$61.11M | -$22.57M | -$9.42M |
| 证券出售收益 | -$1.30M | – | – | – | – |
| 权益法投资收益 | $1.20M | – | – | – | – |
| 特殊收益（费用） | -$7.95M | -$32.20M | -$54.46M | -$22.44M | -$8.13M |
| -减：重组及并购费用 | $8.45M | $32.20M | $54.46M | $22.44M | $8.13M |
| -减：核销 | -$500,000.00 | – | – | – | – |
| 其他非经营性收入（支出） | -$35,000.00 | $1.89M | -$6.65M | -$132,000.00 | -$1.29M |
| 税前利润 | $132.11M | $85.83M | $490.27M | $109.17M | $134.73M |
| 税费 | $28.70M | $17.79M | $65.39M | $1.34M | $4.68M |
| 净利润 | $103.40M | $68.04M | $424.88M | $107.83M | $130.04M |
| 持续经营利润 | $103.40M | $68.04M | $424.88M | $107.83M | $130.04M |
| 归属母公司净利润 | $103.40M | $68.04M | $424.88M | $107.83M | $130.04M |
| 归属普通股股东净利润 | $103.40M | $68.04M | $424.88M | $107.83M | $130.04M |
| 基本每股收益 | $0.50 | $0.33 | $2.06 | $0.52 | $0.63 |
| 摊薄每股收益 | $0.50 | $0.33 | $2.04 | $0.52 | $0.63 |
| 每股股息 | $0.35 | $0.00 | $0.26 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $5.89B | $5.78B | $6.28B | $6.28B | $6.55B |
| 流动资产合计 | $1.66B | $1.54B | $2.00B | $2.00B | $2.53B |
| 现金及现金等价物与短期投资 | $793.50M | $646.29M | $1.10B | $1.10B | $1.69B |
| -现金及现金等价物 | $768.50M | $646.29M | $839.01M | $839.01M | $1.36B |
| -短期投资 | $25.00M | $0.00 | $259.91M | $259.91M | $334.38M |
| 应收款 | $389.85M | $396.62M | $520.03M | $520.03M | $375.56M |
| -应收账款 | $389.85M | $396.62M | $402.61M | $402.61M | $375.56M |
| 存货 | $311.36M | $309.61M | $301.89M | $301.89M | $290.23M |
| 其他流动资产 | $161.92M | $187.74M | – | – | $175.18M |
| 非流动资产合计 | $4.23B | $4.24B | $4.29B | $4.29B | $4.02B |
| 固定资产净值 | $923.04M | $914.79M | $1.08B | $1.08B | $897.64M |
| -固定资产原值 | $1.43B | – | $1.54B | $1.54B | $1.52B |
| -累计折旧 | -$502.18M | – | -$464.97M | -$464.97M | -$621.29M |
| 商誉及其他无形资产 | $3.05B | $3.06B | $3.09B | $3.09B | $2.85B |
| -商誉 | $2.69B | $2.70B | $2.70B | $2.70B | $2.55B |
| -其他无形资产 | $352.35M | $367.49M | $386.43M | $386.43M | $297.18M |
| 其他非流动资产 | $263.79M | $263.55M | $121.98M | $121.98M | $273.26M |
| 负债合计 | $2.53B | $2.45B | $2.50B | $2.50B | $2.90B |
| 流动负债合计 | $581.45M | $479.11M | $512.14M | $512.14M | $973.41M |
| 应付款 | $79.08M | $78.30M | $112.37M | $112.37M | $74.77M |
| -应付账款 | $79.08M | $78.30M | $72.66M | $72.66M | $74.77M |
| 一年内应计费用 | $485.85M | $400.81M | $197.26M | $197.26M | $399.03M |
| 短期债务及融资租赁负债 | $16.52M | – | $28.84M | $28.84M | $499.60M |
| -一年内到期债务 | $16.52M | – | – | – | $499.60M |
| 非流动负债合计 | $1.95B | $1.97B | $1.99B | $1.99B | $1.93B |
| 长期债务及融资租赁负债 | $1.63B | $1.65B | $1.78B | $1.78B | $1.63B |
| -长期债务 | $1.63B | $1.65B | $1.65B | $1.65B | $1.63B |
| 其他非流动负债 | $322.91M | $324.69M | $207.41M | $207.41M | $303.09M |
| 股东权益合计 | $3.36B | $3.33B | $3.78B | $3.78B | $3.65B |
| 股东权益 | $3.36B | $3.33B | $3.78B | $3.78B | $3.65B |
| 股本 | $2.40M | $2.40M | $2.53M | $2.53M | $2.53M |
| -普通股 | $2.40M | $2.40M | $2.53M | $2.53M | $2.53M |
| -优先股 | $0.00 | – | $0.00 | $0.00 | $0.00 |
| 资本公积 | $956.24M | $949.27M | $1.44B | $1.44B | $1.42B |
| 留存收益 | $2.81B | $2.80B | $2.75B | $2.75B | $2.65B |
| 减：库存股 | $13.22M | $25.15M | $31.82M | $31.82M | $36.08M |
| 不影响留存收益的损益 | -$402.67M | -$396.84M | -$377.31M | -$377.31M | -$384.32M |
| -应收税款 | – | – | $64.22M | $64.22M | – |
| -其他应收款 | – | – | $53.21M | $53.21M | – |
| 预付资产 | – | – | $49.26M | $49.26M | – |
| 受限现金 | – | – | $22.53M | $22.53M | – |
| -应付税款合计 | – | – | $39.72M | $39.72M | – |
| -一年内到期融资租赁负债 | – | – | $28.84M | $28.84M | – |
| 一年内递延负债 | – | – | $79.42M | $79.42M | – |
| 其他流动负债 | – | – | $94.25M | $94.25M | – |
| -长期融资租赁负债 | – | – | $129.11M | $129.11M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $200.69M | $100.63M | $654.33M | $188.13M | $165.02M |
| 持续经营经营活动现金流净额 | $200.69M | $100.63M | $654.33M | $188.13M | $165.02M |
| 持续经营净利润 | $103.40M | $68.04M | $424.88M | $107.83M | $130.04M |
| 折旧、折耗与摊销 | $50.56M | $51.21M | $193.75M | $49.39M | $50.97M |
| 递延税款 | $159,000.00 | -$3.48M | -$20.07M | -$19.76M | -$3.48M |
| 其他非现金项目 | $676,000.00 | $2.12M | $16.47M | $3.53M | $3.20M |
| 营运资金变动 | $38.93M | -$42.14M | -$34.51M | $10.64M | -$26.42M |
| -其他流动资产变动 | $29.04M | -$28.33M | -$1.71M | -$2.11M | $449,000.00 |
| -其他流动负债变动 | $23.13M | -$13.80M | $38.34M | $38.84M | -$2.78M |
| 投资活动现金流净额 | -$70.26M | $211.47M | -$305.28M | -$226.47M | -$156.90M |
| 持续经营投资活动现金流净额 | -$70.26M | $211.47M | -$305.28M | -$226.47M | -$156.90M |
| 固定资产购置及出售净额 | -$42.93M | -$46.88M | -$201.05M | -$70.91M | -$46.05M |
| 无形资产购置及出售净额 | -$436,000.00 | -$1.60M | -$6.08M | -$667,000.00 | -$4.40M |
| 投资购置及出售净额 | -$25.25M | $258.92M | $225.24M | $73.87M | -$114.46M |
| 其他投资变动净额 | $217,000.00 | $1.04M | -$32.16M | -$4.13M | $8.01M |
| 筹资活动现金流 | -$8.47M | -$503.66M | -$178.98M | -$478.35M | $614.07M |
| 持续经营筹资活动现金流净额 | -$8.47M | -$503.66M | -$178.98M | -$478.35M | $614.07M |
| 其他筹资费用净额 | $488.28M | -$503.66M | -$332.88M | -$282.12M | -$16.15M |
| 期末现金余额 | $768.50M | $646.29M | $839.01M | $839.01M | $1.36B |
| 现金净变动 | $121.96M | -$191.56M | $170.07M | -$516.68M | $622.19M |
| 期初现金余额 | $646.29M | $839.01M | $663.56M | $1.36B | $733.82M |
| 汇率变动影响 | $251,000.00 | -$1.16M | $5.38M | $92,000.00 | -$412,000.00 |
| 自由现金流 | $157.32M | $52.15M | $447.20M | $116.55M | $114.57M |
| 持续经营损益 | – | – | $968,000.00 | $0.00 | $0.00 |
| -应收款变动 | – | – | -$36.39M | -$22.64M | $8.55M |
| -存货变动 | – | – | -$848,000.00 | -$5.40M | -$939,000.00 |
| -预付资产变动 | – | – | $3.02M | $8.62M | -$2.54M |
| -应付账款及应计费用变动 | – | – | -$51.24M | $23.24M | -$31.59M |
| -其他营运资金变动 | – | – | $14.32M | -$29.92M | $2.43M |
| 业务购买及出售净额 | – | – | -$291.23M | -$224.63M | $0.00 |
| 债务发行及偿还净额 | – | – | $208.15M | -$476.31M | – |
| 已付现金股利 | – | – | -$54.24M | $1,000.00 | – |
| 股票期权行使所得 | – | – | $0.00 | – | – |
| 普通股发行净额 | – | – | – | – | $0.00 |
暂无评论——快来第一个聊聊 QGEN。
登录后参与讨论。